Literature DB >> 8727332

Bone graft in hindfoot arthrodesis: allograft vs autograft.

W C McGarvey1, W G Braly.   

Abstract

From 1990 to 1992, all arthrodeses of the so-called triple joints, combined or isolated and performed by one surgeon, were reviewed to allow a minimum follow up of 18 months from the time of the index procedure. Type of bone graft was selected based on the patients' decision after the risks of each were explained by the surgeon. There were 37 patients undergoing 41 procedures (4 bilateral) including double and triple arthrodesis, as well as isolated subtalar fusions. Twenty-nine of these were performed for either degenerative or posttraumatic arthritis. Ten others were performed for joint incongruity resulting from posterior tibial tendon insufficiency, and the rest for hemiparesis or residual clubfoot. All patients were placed into a routine postoperative regimen of casting, bracing, weight bearing, and therapy. They were evaluated based on subjective complaints, physical examination, and postoperative radiographs. Any patient suspected of having a nonunion underwent a computed tomography scan for confirmation. Overall, 24 patients received allografts and 17 iliac crest grafts. There were four nonunions, three of which utilized banked bone graft, with the only nonunion in the autograft group occurring in a patient following open calcaneus fracture. Of the four nonunions, three opted for revision surgery and the only one to choose allograft again incurred the only recurrent nonunion. There were two infections, one in each group, resulting in prolonged intravenous antibiotic therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8727332     DOI: 10.3928/0147-7447-19960501-08

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  8 in total

1.  Modified Lapidus Procedure with Joint Compression, Meticulous Surface Preparation, and Shear-Strain-Relieved Bone Graft Yields Low Nonunion Rate.

Authors:  Sriniwasan B Mani; Eric W Lloyd; Aoife MacMahon; Matthew M Roberts; David S Levine; Scott J Ellis
Journal:  HSS J       Date:  2015-08-29

2.  Long-term results of in situ subtalar arthrodesis.

Authors:  Pierre Joveniaux; Alain Harisboure; Xavier Ohl; Emile Dehoux
Journal:  Int Orthop       Date:  2010-06-16       Impact factor: 3.075

Review 3.  Triple Arthrodesis for Adult-Acquired Flatfoot Deformity.

Authors:  Maj Uma E Erard; Maj Andrew J Sheean; Bruce J Sangeorzan
Journal:  Foot Ankle Orthop       Date:  2019-08-19

4.  The Use of 3D-Printed Custom-Made Implants as an Attractive Potential Alternative to the Treatment of Segmental Bone Loss in Foot and Ankle.

Authors:  Silvio Caravelli; Giuseppe Ambrosino; Alberto Grassi; Stefano Zaffagnini; Massimiliano Mosca
Journal:  J Clin Med       Date:  2022-08-13       Impact factor: 4.964

Review 5.  Substitutes of structural and non-structural autologous bone grafts in hindfoot arthrodeses and osteotomies: a systematic review.

Authors:  Marc Andreas Müller; Alexander Frank; Matthias Briel; Victor Valderrabano; Patrick Vavken; Vahid Entezari; Arne Mehrkens
Journal:  BMC Musculoskelet Disord       Date:  2013-02-07       Impact factor: 2.362

6.  Patient-specific three-dimensional printed hemi talar prostheses for the treatment of talar osteonecrosis, case report and literature review.

Authors:  Jorge Javier Del Vecchio; Lucas Nicolás Chemes; Luciano Bertollotti; Mauricio Esteban Ghioldi; Eric Daniel Dealbera; Marcos Galli Serra; Walter Parizzia
Journal:  SAGE Open Med Case Rep       Date:  2020-06-02

7.  Five-Year Follow-Up of Distal Tibia Bone and Foot and Ankle Trauma Treated with a 3D-Printed Titanium Cage.

Authors:  Eugene C Nwankwo; Fangyu Chen; Dana L Nettles; Samuel B Adams
Journal:  Case Rep Orthop       Date:  2019-11-26

8.  Grice subtalar arthrodesis of bilateral adult flatfoot in a professional dancer: a case report.

Authors:  Alessio Pedrazzini; Paolo Bastia; Nicola Bertoni; Francesco Ceccarelli; Francesco Pogliacomi
Journal:  Acta Biomed       Date:  2021-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.